1.Clinical Observation on Tianmeng Lingjiao Formula(天礞羚角方) as an Adjunctive Therapy for Paroxysmal Atrial Fibrillation with Phlegm-Heat Harassing the Interior Syndrome
Jiafan CHEN ; Chenglin DUAN ; Yihang DU ; Lianfen QI ; Xinjue SHAN ; Jiaqi LI ; Wenjing ZHANG ; Tao CHENG ; Bochao JIA ; Zizhen CHEN ; Jingjing SHI ; Yuguang CHU ; Yuwen SUN ; Yuanhui HU
Journal of Traditional Chinese Medicine 2026;67(20):2195-2201
ObjectiveTo observe the clinical efficacy and safety of Tianmeng Lingjiao Formula(天礞羚角方, TLF) as an adjunctive therapy for paroxysmal atrial fibrillation (PAF) with phlegm-heat harassing the interior syndrome. MethodsNinety patients with PAF and phlegm-heat harassing the interior syndrome were enrolled and randomly assigned in a 2∶1 ratio to test group (60 cases) and control group (30 cases). The control group received conventional western medicine, while the test group received TLF in addition to the conventional treatment, with one dose administered daily. The treatment course for both groups was 4 weeks. The efficacy of traditional Chinese medicine (TCM) syndrome and the rate of atrial fibrillation (AF) conversion were compared between groups. Assessments included AF burden, frequency and duration of AF episodes, TCM syndrome scores, and European Heart Rhythm Association (EHRA) AF symptom classification before and after treatment. Safety indicators such as blood routine, urine routine, stool routine, liver function, kidney function, and electrolytes were also monitored. Adverse events were recorded. ResultsA total of 82 patients completed the study (54 in the test group and 28 in the control group). After treatment, AF burden, the frequency and duration of AF episodes, and TCM syndrome scores were significantly reduced in both groups, and the test group showed lower indicators than the control group (P<0.01 or P<0.05). The AF conversion rate was 25.93% (14/54) in the test group, significantly higher than 3.57% (1/28) in the control group (P<0.05). The total effective rate for TCM syndrome efficacy was 83.33% (45/54) in the test group, which was significantly higher than 67.86% (19/28) in the control group (P<0.05). After treatment, the EHRA atrial fibrillation symptom severity in the test group showed significant improvement, and the improvement in atrial fibrillation symptoms was superior to that in the control group (P<0.01or P<0.05). No significant abnormalities were observed in safety indicators, and no adverse events occurred during the trial. ConclusionTLF as an adjunctive therapy can reduce AF burden, enhance the conversion rate of AF, decrease the frequency and duration of episodes, and improve clinical symptoms in patients with paroxysmal atrial fibrillation presenting with phlegm-heat harassing the interior syndrome, with a favorable safety profile.
2.The revascular and transplanted effects of vascular endothelial cells on islets grafts
Zizhao JIAO ; Wujun XUE ; Yuanzhu SUN ; Yang LI ; Maozhu AN ; Haixia FU ; Fenglou LI ; Lianfen SHENG
Chinese Journal of Endocrinology and Metabolism 2018;34(6):516-521
Objective To investigate the revascular and transplanted effects of islet grafts after co-transplantation with vascular endothelial cells ( ECs) in diabetic rats. Methods The rat ECs and islet cells were isolated and purified, then subcutaneously co-transplanted to the inbred SD male rats with diabetes mellitus, the group of islets transplanted alone, group of phosphate buffered solution, and group of normal rats served as control. Islet grafts revascularization degree, islet cells activity and apoptosis were observed by immunohistochemical double staining of CD31, insulin and factor associated suicide (Fas) antibody. The results of intraperitoneal glucose tolerance test (IPGTT) and intraperitoneal insulin tolerance test (IPITT), the blood glucose and insulin levels of the rats and the survival time of the islet grafts were compared. Results The blood glucose concentrations of IPGTT and IPITT, the blood glucose and insulin levels of rats analyzed by multivariate analysis in the ECs and islets transplantation group were better than those in the islets transplantation alone group (P<0.05). The islet grafts mean survival time of the ECs and islets transplantation group was longer than that of the islets transplantation alone group (P<0.05). On the 7th day after transplantation, mean microvascular density of islet grafts per square millimeter in the ECs and islets transplantation group was 26.4 ± 6.1, significantly greater than that in the islets transplantation alone group 18.3 ± 5.7 (P<0.05). In the ECs and islets transplantation group, insulin staining intensity was higher than that in the islets transplantation alone group (P<0.05), while factor associated suicide(Fas) staining intensity was lower than that in the islets transplantation alone group ( P<0. 05 ). Conclusion Co-transplantation with ECs could promote the revascularization of islet grafts and improve the effect of islet transplantation.
3.Experimental study of Huanglian Pikang tincture for anti-cutaneous-fungal action
Chao CHEN ; Lianfen SUN ; Ya PENG
Chinese Journal of Clinical Pharmacology and Therapeutics 2000;0(02):-
AIM: To observe the antifungal action of Huanglian Pikang tincture (HPT). METHODS: An anifungal experiment was performed in vitro. RESULTS: HPT had obvious antibacterial actions for the trichophyton rubrum, T. interdigital, epidermophyton floccosum, candida albicans and lessened the colonies (n=5, P

Result Analysis
Print
Save
E-mail